ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

SNG Synairgen Plc

4.35
-0.325 (-6.95%)
Last Updated: 12:06:55
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Synairgen Plc LSE:SNG London Ordinary Share GB00B0381Z20 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.325 -6.95% 4.35 4.01 4.99 4.41 4.35 4.39 401,311 12:06:55
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -17.65M -0.0876 -0.50 9.41M
Synairgen Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SNG. The last closing price for Synairgen was 4.68p. Over the last year, Synairgen shares have traded in a share price range of 3.65p to 10.62p.

Synairgen currently has 201,374,975 shares in issue. The market capitalisation of Synairgen is £9.41 million. Synairgen has a price to earnings ratio (PE ratio) of -0.50.

Synairgen Share Discussion Threads

Showing 36276 to 36299 of 99175 messages
Chat Pages: Latest  1459  1458  1457  1456  1455  1454  1453  1452  1451  1450  1449  1448  Older
DateSubjectAuthorDiscuss
22/10/2020
23:57
Another collaboration,,,
bobaxe1
22/10/2020
23:45
More spam for youhttps://twitter.com/DDWJournal/status/1319218069894582272?s=19
bobaxe1
22/10/2020
23:43
https://twitter.com/Aerogen/status/1319329532118208512?s=19
bobaxe1
22/10/2020
23:43
Collaboration
bobaxe1
22/10/2020
21:34
Make sure you grab as much as you can at these silly prices, look at DDDD they just merged and there heading towards 200p. Our time is coming and where multi times larger!
nasnas1
22/10/2020
20:16
Several other teams are exploring inhaled drugs to treat COVID-19. A team led by scientists at the University of Pittsburgh School of Medicine recently developed a drug that’s based on an antibody component 10 times smaller than a full-sized antibody. The drug blocked SARS-CoV-2 in hamsters, and a startup called Abound Bio is looking to move the candidate into clinical trials as an inhaled therapy.

U.K. biotech Synairgen, meanwhile, recently said its inhaled formulation of interferon beta, called SNG001, cut the risk of developing severe COVID-19 by 79% compared to placebo among patients in a double-blind trial. Patients who got the drug were also more than twice as likely to recover from COVID-19.

2seabass
22/10/2020
19:46
It's not REALLY galling SJ, because I put my trading pot (which I sold at 192p) in to NCYT yesterday, and it's 15% up already.My intention is to sell that tomorrow, and buy more SNG shares, and I'm expecting that to be at or around the placing place.If it comes off, it was a nice piece of business.But as you and I know full well, a lot can go wrong between one day and the next.
festario
Chat Pages: Latest  1459  1458  1457  1456  1455  1454  1453  1452  1451  1450  1449  1448  Older

Your Recent History

Delayed Upgrade Clock